152 related articles for article (PubMed ID: 2403571)
1. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.
Ulick S; Tedde R; Mantero F
J Clin Endocrinol Metab; 1990 Jan; 70(1):200-6. PubMed ID: 2403571
[TBL] [Abstract][Full Text] [Related]
2. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess.
Ulick S; Tedde R; Wang JZ
J Clin Endocrinol Metab; 1992 Mar; 74(3):593-9. PubMed ID: 1740492
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
4. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
5. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
6. Apparent mineralocorticoid excess type II.
Mantero F; Tedde R; Opocher G; Dessi Fulgheri P; Arnaldi G; Ulick S
Steroids; 1994 Feb; 59(2):80-3. PubMed ID: 8191552
[TBL] [Abstract][Full Text] [Related]
7. Steroids and hypertension.
Mantero F; Armanini D; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
J Steroid Biochem Mol Biol; 1991; 40(1-3):35-44. PubMed ID: 1958539
[TBL] [Abstract][Full Text] [Related]
8. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Al-Harbi T; Al-Shaikh A
J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
[TBL] [Abstract][Full Text] [Related]
9. A new form of the syndrome of apparent mineralocorticoid excess.
Ulick S; Chan CK; Rao KN; Edassery J; Mantero F
J Steroid Biochem; 1989 Jan; 32(1B):209-12. PubMed ID: 2913411
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
Stewart PM; Whorwood CB; Walker BR
Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
[TBL] [Abstract][Full Text] [Related]
11. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
Rodríguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
12. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess.
Tedde R; Pala A; Melis A; Ulick S
J Endocrinol Invest; 1992 Jun; 15(6):471-4. PubMed ID: 1401749
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
[TBL] [Abstract][Full Text] [Related]
14. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
Ulick S; Wang JZ; Hanukoglu A; Rösler A
J Lab Clin Med; 1993 Dec; 122(6):673-6. PubMed ID: 8245686
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
New MI; Levine LS; Biglieri EG; Pareira J; Ulick S
J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517
[TBL] [Abstract][Full Text] [Related]
16. Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
Harinck HI; van Brummelen P; Van Seters AP; Moolenaar AJ
Clin Endocrinol (Oxf); 1984 Nov; 21(5):505-14. PubMed ID: 6094045
[TBL] [Abstract][Full Text] [Related]
17. Apparent mineralocorticoid excess.
Benediktsson R; Edwards CR
J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
[TBL] [Abstract][Full Text] [Related]
18. New findings in apparent mineralocorticoid excess.
DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI
Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
[TBL] [Abstract][Full Text] [Related]
19. Hypertension and the cortisol-cortisone shuttle.
Quinkler M; Stewart PM
J Clin Endocrinol Metab; 2003 Jun; 88(6):2384-92. PubMed ID: 12788832
[TBL] [Abstract][Full Text] [Related]
20. Apparent mineralocorticoid excess: type I and type II.
Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH
Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
